Endocytosis of glycosylphosphatidylinositol-anchored proteins

Journal of Biomedical Science

Volumn 16, Issue 1, 2009, Pages

  Lakhan, Shaheen E ^a   Sabharanjak, Shefali ^a   De, Ananya ^a  

^a Global Neuroscience Initiative Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLATHRIN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; GLYCOSYLPHOSPHATIDYLINOSITOL; LIPID; PROTEIN; SPHINGOLIPID;

CELL SURFACE; COATED PIT; ENDOCYTOSIS; HUMAN; IMMUNE RESPONSE; LIPID RAFT; NONHUMAN; NUTRIENT UPTAKE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; CELL MEMBRANE; CHEMISTRY; METABOLISM; MUTATION; PRION;

MAMMALIA;

ANIMALS; CELL MEMBRANE; CLATHRIN; ENDOCYTOSIS; GLYCOSYLPHOSPHATIDYLINOSITOLS; HUMANS; LIPIDS; MEMBRANE MICRODOMAINS; MODELS, BIOLOGICAL; MUTATION; PRIONS; PROTEINS; SIGNAL TRANSDUCTION; SPHINGOLIPIDS;

EID: 70350322116     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-16-93     Document Type: Review

References (96)

1. Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. M Bessler PJ Mason P Hillmen T Miyata N Yamada J Takeda L Luzzatto T Kinoshita, Embo J 1994 13 110 117 8306954
2. Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency. AM Almeida Y Murakami DM Layton P Hillmen GS Sellick Y Maeda S Richards S Patterson I Kotsianidis L Mollica, et al. Nat Med 2006 12 846 851 10.1038/nm1410 16767100
3. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. B Chesebro M Trifilo R Race K Meade-White C Teng R LaCasse L Raymond C Favara G Baron S Priola, et al. Science 2005 308 1435 1439 10.1126/science.1110837 15933194
4. Mutations of FBN1 and genotype-phenotype correlations in Marfan syndrome and related fibrillinopathies. PN Robinson P Booms S Katzke M Ladewig L Neumann M Palz R Pregla F Tiecke T Rosenberg, Hum Mutat 2002 20 153 161 10.1002/humu.10113 12203987 (Pubitemid 34966843)
5. Correlations of genotype and phenotype in hypophosphatasia. L Zurutuza F Muller JF Gibrat A Taillandier B Simon-Bouy JL Serre E Mornet, Hum Mol Genet 1999 8 1039 1046 10.1093/hmg/8.6.1039 10332035
6. Familial chylomicronemia (type I hyperlipoproteinemia) due to a single missense mutation in the lipoprotein lipase gene. D Ameis J Kobayashi RC Davis O Ben-Zeev MJ Malloy JP Kane G Lee H Wong RJ Havel MC Schotz, J Clin Invest 1991 87 1165 1170 10.1172/JCI115114 2010533
7. Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene. M Veugelers BD Cat SY Muyldermans G Reekmans N Delande S Frints E Legius JP Fryns C Schrander-Stumpel B Weidle, et al. Hum Mol Genet 2000 9 1321 1328 10.1093/hmg/9.9.1321 10814714
8. GPI-anchored proteins are directly targeted to the apical surface in fully polarized MDCK cells. S Paladino T Pocard MA Catino C Zurzolo, J Cell Biol 2006 172 1023 1034 10.1083/jcb.200507116 16549497
9. Growth factor induction of Cripto-1 shedding by glycosylphosphatidylinositol-phospholipase D and enhancement of endothelial cell migration. K Watanabe C Bianco L Strizzi S Hamada M Mancino V Bailly W Mo D Wen K Miatkowski M Gonzales, et al. J Biol Chem 2007 282 31643 31655 10.1074/jbc.M702713200 17720976
10. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. JF Ross PK Chaudhuri M Ratnam, Cancer 1994 73 2432 2443 10.1002/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S 7513252
11. The plasminogen activation system in tumor growth, invasion, and metastasis. PA Andreasen R Egelund HH Petersen, Cell Mol Life Sci 2000 57 25 40 10.1007/s000180050497 10949579
12. Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses. SY Chan CJ Empig FJ Welte RF Speck A Schmaljohn JF Kreisberg MA Goldsmith, Cell 2001 106 117 126 10.1016/S0092-8674(01)00418-4 11461707
13. Glycosylphosphatidylinositol anchors of membrane glycoproteins are binding determinants for the channel-forming toxin aerolysin. DB Diep KL Nelson SM Raja EN Pleshak JT Buckley, J Biol Chem 1998 273 2355 2360 10.1074/jbc.273.4.2355 9442081
14. Clostridium septicum alpha toxin uses glycosylphosphatidylinositol- anchored protein receptors. VM Gordon KL Nelson JT Buckley VL Stevens RK Tweten PC Elwood SH Leppla, J Biol Chem 1999 274 27274 27280 10.1074/jbc.274.38.27274 10480947
15. Neural tube and craniofacial defects with special emphasis on folate pathway genes. RH Finnell KA Greer RC Barber JA Piedrahita, Crit Rev Oral Biol Med 1998 9 38 53 10.1177/10454411980090010201 9488247
16. In utero physiology: role of folic acid in nutrient delivery and fetal development. AC Antony, Am J Clin Nutr 2007 85 598S 603S 17284762
17. Folate receptor allows cells to grow in low concentrations of 5-methyltetrahydrofolate. H Matsue KG Rothberg A Takashima BA Kamen RG Anderson SW Lacey, Proc Natl Acad Sci USA 1992 89 6006 6009 10.1073/pnas.89.13.6006 1631087
18. Folate receptors targeted to clathrin-coated pits cannot regulate vitamin uptake. TE Ritter O Fajardo H Matsue RG Anderson SW Lacey, Proc Natl Acad Sci USA 1995 92 3824 3828 10.1073/pnas.92.9.3824 7731991
19. Prions - infectious pathogens causing the spongiform encephalopathies. SB Prusiner DT Kingsbury, CRC Crit Rev Clin Neurobiol 1985 1 181 200 3915974
20. Human prion diseases. SB Prusiner KK Hsiao, Ann Neurol 1994 35 385 395 10.1002/ana.410350404 8154865
21. Molecular biology and pathogenesis of prion diseases. SB Prusiner, Trends Biochem Sci 1996 21 482 487 10.1016/S0968-0004(96)10063-3 9009832
22. Evidence for synthesis of scrapie prion proteins in the endocytic pathway. DR Borchelt A Taraboulos SB Prusiner, J Biol Chem 1992 267 16188 16199 1353761
23. Synthesis and trafficking of prion proteins in cultured cells. A Taraboulos AJ Raeber DR Borchelt D Serban SB Prusiner, Mol Biol Cell 1992 3 851 863 1356522
24. Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation. K Doh-Ura T Iwaki B Caughey, J Virol 2000 74 4894 4897 10.1128/JVI.74.10.4894-4897.2000 10775631
25. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. A Taraboulos M Scott A Semenov D Avrahami L Laszlo SB Prusiner, J Cell Biol 1995 129 121 132 10.1083/jcb.129.1.121 7698979
26. Prion protein: a pattern recognition receptor for viral components and uric acid responsible for the induction of innate and adaptive immunity. SM McBride, Med Hypotheses 2005 65 570 577 10.1016/j.mehy.2005.02.038 15913900
27. A pore-forming toxin interacts with a GPI-anchored protein and causes vacuolation of the endoplasmic reticulum. L Abrami M Fivaz PE Glauser RG Parton FG van der Goot, J Cell Biol 1998 140 525 540 10.1083/jcb.140.3.525 9456314
28. Channels formed by subnanomolar concentrations of the toxin aerolysin trigger apoptosis of T lymphomas. KL Nelson RA Brodsky JT Buckley, Cell Microbiol 1999 1 69 74 10.1046/j.1462-5822.1999.00009.x 11207542
29. Resistance of paroxysmal nocturnal hemoglobinuria cells to the glycosylphosphatidylinositol-binding toxin aerolysin. RA Brodsky GL Mukhina KL Nelson TS Lawrence RJ Jones JT Buckley, Blood 1999 93 1749 1756 10029605
30. Oligomerization of the channel-forming toxin aerolysin precedes insertion into lipid bilayers. FG van der Goot F Pattus KR Wong JT Buckley, Biochemistry 1993 32 2636 2642 10.1021/bi00061a023 7680572
31. Plasma membrane microdomains act as concentration platforms to facilitate intoxication by aerolysin. L Abrami FG van Der Goot, J Cell Biol 1999 147 175 184 10.1083/jcb.147.1.175 10508864
32. High cell sensitivity to Helicobacter pylori VacA toxin depends on a GPI-anchored protein and is not blocked by inhibition of the clathrin-mediated pathway of endocytosis. V Ricci A Galmiche A Doye V Necchi E Solcia P Boquet, Mol Biol Cell 2000 11 3897 3909 11071915
33. Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry. DR Shafren DJ Dorahy RA Ingham GF Burns RD Barry, J Virol 1997 71 4736 4743 9151867
34. A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells. DR Shafren DT Williams RD Barry, J Virol 1997 71 9844 9848 9371658
35. Enterovirus receptors and virus replication in human leukocytes. T Vuorinen R Vainionpaa J Heino T Hyypia, J Gen Virol 1999 80 Pt 4 921 927 10211961
36. The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55). TM Karnauchow DL Tolson BA Harrison E Altman DM Lublin K Dimock, J Virol 1996 70 5143 5152 8764022
37. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. JM Bergelson M Chan KR Solomon NF St John H Lin RW Finberg, Proc Natl Acad Sci USA 1994 91 6245 6248 10.1073/pnas.91.13.6245 7517044
38. Nonopsonic phagocytosis of Mycobacterium kansasii by human neutrophils depends on cholesterol and is mediated by CR3 associated with glycosylphosphatidylinositol-anchored proteins. P Peyron C Bordier EN N'Diaye I Maridonneau-Parini, J Immunol 2000 165 5186 5191 11046051
39. Recruitment of CD55 and CD66e brush border-associated glycosylphosphatidylinositol-anchored proteins by members of the Afa/Dr diffusely adhering family of Escherichia coli that infect the human polarized intestinal Caco-2/TC7 cells. J Guignot I Peiffer MF Bernet-Camard DM Lublin C Carnoy SL Moseley AL Servin, Infect Immun 2000 68 3554 3563 10.1128/IAI.68.6. 3554-3563.2000 10816511 (Pubitemid 30340457)
40. Role of decay-accelerating factor domains and anchorage in internalization of Dr-fimbriated Escherichia coli. R Selvarangan P Goluszko V Popov J Singhal T Pham DM Lublin S Nowicki B Nowicki, Infect Immun 2000 68 1391 1399 10.1128/IAI.68.3.1391-1399.2000 10678952
41. CD66 carcinoembryonic antigens mediate interactions between Opa-expressing Neisseria gonorrhoeae and human polymorphonuclear phagocytes. SD Gray-Owen C Dehio A Haude F Grunert TF Meyer, Embo J 1997 16 3435 3445 10.1093/emboj/16.12.3435 9218786
42. Microdomains in lymphocyte signalling: beyond GPI-anchored proteins. S Ilangumaran HT He DC Hoessli, Immunol Today 2000 21 2 7 10.1016/S0167-5699(99) 01494-2 10637551
43. Functional role played by the glycosylphosphatidylinositol anchor glycan of CD48 in interleukin-18-induced interferon-gamma production. K Fukushima Y Ikehara K Yamashita, J Biol Chem 2005 280 18056 18062 10.1074/jbc.M413297200 15760905
44. Cellular prion protein promotes invasion and metastasis of gastric cancer. Y Pan L Zhao J Liang J Liu Y Shi N Liu G Zhang H Jin J Gao H Xie, et al. Faseb J 2006 20 1886 1888 10.1096/fj.06-6138fje 16877520
45. Cripto localizes Nodal at the limiting membrane of early endosomes. MH Blanchet JA Le Good V Oorschot S Baflast G Minchiotti J Klumperman DB Constam, Sci Signal 2008 1 a13 10.1126/scisignal.1165027 19001664
46. Internalization of glycosyl-phosphatidylinositol (GPI)-anchored lymphocyte proteins. II. GPI-anchored and transmembrane molecules internalize through distinct pathways. A Bamezai VS Goldmacher KL Rock, Eur J Immunol 1992 22 15 21 10.1002/eji.1830220104 1346109
47. Effect of ras-activation on the expression of glycosyl- phosphatidylinositol-anchored proteins on the plasma membrane. A Bamezai KL Rock, Oncogene 1991 6 1445 1451 1679532
48. Endocytosis of glycophospholipid-anchored and transmembrane forms of CD4 by different endocytic pathways. GA Keller MW Siegel IW Caras, Embo J 1992 11 863 874 1532143
49. Endocytosis of GPI-anchored proteins in human lymphocytes: role of glycolipid-based domains, actin cytoskeleton, and protein kinases. M Deckert M Ticchioni A Bernard, J Cell Biol 1996 133 791 799 10.1083/jcb.133.4.791 8666664
50. Sequestration of GPI-anchored proteins in caveolae triggered by cross-linking. S Mayor KG Rothberg FR Maxfield, Science 1994 264 1948 1951 10.1126/science.7516582 7516582
51. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. DA Brown JK Rose, Cell 1992 68 533 544 10.1016/0092-8674(92)90189-J 1531449
52. Insolubility and redistribution of GPI-anchored proteins at the cell surface after detergent treatment. S Mayor FR Maxfield, Mol Biol Cell 1995 6 929 944 7579703
53. Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recycles. BA Kamen MT Wang AJ Streckfuss X Peryea RG Anderson, J Biol Chem 1988 263 13602 13609 3417674
54. Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate. KG Rothberg YS Ying BA Kamen RG Anderson, J Cell Biol 1990 111 2931 2938 10.1083/jcb.111.6.2931 2148564
55. GPI-anchored proteins, glycosphingolipids, and sphingomyelin are sequestered to caveolae only after crosslinking. T Fujimoto, J Histochem Cytochem 1996 44 929 941 8756764
56. Regulated internalization of caveolae. RG Parton B Joggerst K Simons, J Cell Biol 1994 127 1199 1215 10.1083/jcb.127.5.1199 7962085
57. Role of GTP hydrolysis in fission of caveolae directly from plasma membranes. JE Schnitzer P Oh DP McIntosh, Science 1996 274 239 242 10.1126/science.274.5285.239 8824187
58. Cholesterol-dependent retention of GPI-anchored proteins in endosomes. S Mayor S Sabharanjak FR Maxfield, Embo J 1998 17 4626 4638 10.1093/emboj/17.16. 4626 9707422
59. GPI-anchored proteins are delivered to recycling endosomes via a distinct cdc42-regulated, clathrin-independent pinocytic pathway. S Sabharanjak P Sharma RG Parton S Mayor, Dev Cell 2002 2 411 423 10.1016/S1534-5807(02)00145-4 11970892
60. GPI-anchored proteins are organized in submicron domains at the cell surface. R Varma S Mayor, Nature 1998 394 798 801 10.1038/29563 9723621
61. Cholesterol level regulates endosome motility via Rab proteins. H Chen J Yang PS Low JX Cheng, Biophys J 2008 94 1508 1520 10.1529/biophysj.106.099366 17981910
62. GPI-anchoring leads to sphingolipid-dependent retention of endocytosed proteins in the recycling endosomal compartment. S Chatterjee ER Smith K Hanada VL Stevens S Mayor, Embo J 2001 20 1583 1592 10.1093/emboj/20.7.1583 11285223
63. Ganglioside GM1, a molecular target for immunological and toxic attacks: similarity of neuropathological lesions induced by ganglioside-antiserum and cholera toxin. B Schwerer H Lassmann K Kitz H Bernheimer, Acta Neuropathol 1986 72 55 61 10.1007/BF00687947 3825507
64. Ultrastructural identification of uncoated caveolin-independent early endocytic vehicles. M Kirkham A Fujita R Chadda SJ Nixon TV Kurzchalia DK Sharma RE Pagano JF Hancock S Mayor RG Parton, J Cell Biol 2005 168 465 476 10.1083/jcb.200407078 15668297
65. Cholesterol-sensitive Cdc42 activation regulates actin polymerization for endocytosis via the GEEC pathway. R Chadda MT Howes SJ Plowman JF Hancock RG Parton S Mayor, Traffic 2007 8 702 717 10.1111/j.1600-0854.2007.00565.x 17461795
66. Cholera toxin binds to lipid rafts but has a limited specificity for ganglioside GM1. N Blank M Schiller S Krienke G Wabnitz AD Ho HM Lorenz, Immunol Cell Biol 2007 85 378 382 10.1038/sj.icb.7100045 17325693
67. Aluminum fluoride stimulates surface protrusions in cells overexpressing the ARF6 GTPase. H Radhakrishna RD Klausner JG Donaldson, J Cell Biol 1996 134 935 947 10.1083/jcb.134.4.935 8769418
68. ADP-ribosylation factor 6 regulates a novel plasma membrane recycling pathway. H Radhakrishna JG Donaldson, J Cell Biol 1997 139 49 61 10.1083/jcb.139.1.49 9314528
69. A tubular EHD1-containing compartment involved in the recycling of major histocompatibility complex class I molecules to the plasma membrane. S Caplan N Naslavsky LM Hartnell R Lodge RS Polishchuk JG Donaldson JS Bonifacino, Embo J 2002 21 2557 2567 10.1093/emboj/21.11.2557 12032069
70. Characterization of a nonclathrin endocytic pathway: membrane cargo and lipid requirements. N Naslavsky R Weigert JG Donaldson, Mol Biol Cell 2004 15 3542 3552 10.1091/mbc.E04-02-0151 15146059
71. Arf6-independent GPI-anchored protein-enriched early endosomal compartments fuse with sorting endosomes via a Rab5/phosphatidylinositol-3'- kinase-dependent machinery. M Kalia S Kumari R Chadda MM Hill RG Parton S Mayor, Mol Biol Cell 2006 17 3689 3704 10.1091/mbc.E05-10-0980 16760436
72. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. L Pelkmans J Kartenbeck A Helenius, Nat Cell Biol 2001 3 473 483 10.1038/35074539 11331875
73. Plasmin promotes keratinocyte migration and phagocytic-killing accompanied by suppression of cell proliferation which may facilitate re-epithelialization of wound beds. I Szabo M Simon Jr J Hunyadi, Clin Dev Immunol 2004 11 233 240 10.1080/17402520400001710 15559369
74. Plasminogen activator/plasmin system: a major player in wound healing? WY Li SS Chong EY Huang TL Tuan, Wound Repair Regen 2003 11 239 247 10.1046/j.1524-475X.2003.11402.x 12846910
75. Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity. RP Czekay TA Kuemmel RA Orlando MG Farquhar, Mol Biol Cell 2001 12 1467 1479 11359936
76. Monomer dimer dynamics and distribution of GPI-anchored uPAR are determined by cell surface protein assemblies. VR Caiolfa M Zamai G Malengo A Andolfo CD Madsen J Sutin MA Digman E Gratton F Blasi N Sidenius, J Cell Biol 2007 179 1067 1082 10.1083/jcb.200702151 18056417
77. Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins. RP Czekay K Aertgeerts SA Curriden DJ Loskutoff, J Cell Biol 2003 160 781 791 10.1083/jcb.200208117 12615913
78. The urokinase receptor and integrins in cancer progression. CH Tang Y Wei, Cell Mol Life Sci 2008 65 1916 1932 10.1007/s00018-008-7573-9 18345479
79. Gangliosides inhibit urokinase-type plasminogen activator (uPA)-dependent squamous carcinoma cell migration by preventing uPA receptor/alphabeta integrin/epidermal growth factor receptor interactions. XQ Wang P Sun AS Paller, J Invest Dermatol 2005 124 839 848 10.1111/j.0022-202X.2005.23669.x 15816844
80. A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. SL Shyng MT Huber DA Harris, J Biol Chem 1993 268 15922 15928 8101844
81. A glycolipid-anchored prion protein is endocytosed via clathrin-coated pits. SL Shyng JE Heuser DA Harris, J Cell Biol 1994 125 1239 1250 10.1083/jcb.125.6.1239 7911471
82. Copper stimulates endocytosis of the prion protein. PC Pauly DA Harris, J Biol Chem 1998 273 33107 33110 10.1074/jbc.273.50.33107 9837873
83. Ablation of the metal ion-induced endocytosis of the prion protein by disease-associated mutation of the octarepeat region. WS Perera NM Hooper, Curr Biol 2001 11 519 523 10.1016/S0960-9822(01)00147-6 11413003
84. Endocytic intermediates involved with the intracellular trafficking of a fluorescent cellular prion protein. AC Magalhaes JA Silva KS Lee VR Martins VF Prado SS Ferguson MV Gomez RR Brentani MA Prado, J Biol Chem 2002 277 33311 33318 10.1074/jbc.M203661200 12070160
85. Complementary hydropathy identifies a cellular prion protein receptor. VR Martins E Graner J Garcia-Abreu SJ de Souza AF Mercadante SS Veiga SM Zanata VM Neto RR Brentani, Nat Med 1997 3 1376 1382 10.1038/nm1297-1376 9396608
86. Mechanism of the metal-mediated endocytosis of the prion protein. NM Hooper DR Taylor NT Watt, Biochem Soc Trans 2008 36 1272 1276 10.1042/BST0361272 19021539
87. LRP1 controls biosynthetic and endocytic trafficking of neuronal prion protein. CJ Parkyn EG Vermeulen RC Mootoosamy C Sunyach C Jacobsen C Oxvig S Moestrup Q Liu G Bu A Jen RJ Morris, J Cell Sci 2008 121 773 783 10.1242/jcs.021816 18285446
88. The low-density lipoprotein receptor-related protein 1 (LRP1) mediates the endocytosis of the cellular prion protein. DR Taylor NM Hooper, Biochem J 2007 402 17 23 10.1042/BJ20061736 17155929
89. COOH-terminal sequence of the cellular prion protein directs subcellular trafficking and controls conversion into the scrapie isoform. K Kaneko M Vey M Scott S Pilkuhn FE Cohen SB Prusiner, Proc Natl Acad Sci USA 1997 94 2333 2338 10.1073/pnas.94.6.2333 9122195
90. A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH. S Hornemann R Glockshuber, Proc Natl Acad Sci USA 1998 95 6010 6014 10.1073/pnas.95.11.6010 9600908
91. pH-dependent prion protein conformation in classical Creutzfeldt-Jakob disease. G Zanusso A Farinazzo M Fiorini M Gelati A Castagna PG Righetti N Rizzuto S Monaco, J Biol Chem 2001 276 40377 40380 10.1074/jbc.C100458200 11682490
92. Differential sorting and fate of endocytosed GPI-anchored proteins. M Fivaz F Vilbois S Thurnheer C Pasquali L Abrami PE Bickel RG Parton FG van der Goot, Embo J 2002 21 3989 4000 10.1093/emboj/cdf398 12145200
93. Endocytic trafficking of glycosphingolipids in sphingolipid storage diseases. RE Pagano, Philos Trans R Soc Lond B Biol Sci 2003 358 885 891 10.1098/rstb.2003.1275 12803922
94. The GTPase-activating protein GRAF1 regulates the CLIC/GEEC endocytic pathway. R Lundmark GJ Doherty MT Howes K Cortese Y Vallis RG Parton HT McMahon, Curr Biol 2008 18 1802 1808 10.1016/j.cub.2008.10.044 19036340
95. Lowering the cholesterol content of MA104 cells inhibits receptor-mediated transport of folate. WJ Chang KG Rothberg BA Kamen RG Anderson, J Cell Biol 1992 118 63 69 10.1083/jcb.118.1.63 1618907
96. GM1-containing lipid rafts are depleted within clathrin-coated pits. BJ Nichols, Curr Biol 2003 13 686 690 10.1016/S0960-9822(03)00209-4 12699627